CoChat

Role of Hepatitis E Virus Infection in North American Patients With Severe Acute Liver Injury

Open access
Fontana, Robert J., Engle, Ronald E., Gottfried, Michelle, Hammed, Bilal, Hanje, James, Durkalski, Valerie, Kleiner, David E., Nguyen, Hanh, Nishimura, Norihisa, Lee, William M., Farci, Patrizia, for the Acute Liver Failure Study Group · 2020 · Clinical and Translational Gastroenterology

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: The aim of this study was to determine the role of hepatitis E virus (HEV) infection in a large cohort of prospectively enrolled patients with severe acute liver injury (ALI). METHODS: Serum samples from 594 consecutive adults enrolled between 2008 and 2018 in the US Acute Liver Failure Study Group ALI registry were tested for anti-HEV IgM and anti-HEV IgG levels. Those with detectable anti-HEV IgM underwent further testing for HEV RNA using real-time polymerase chain reaction. RESULTS: The median age of patients was 38 years; 41% were men and 72% Caucasian. Etiologies of ALI included acetaminophen hepatotoxicity (50%), autoimmune hepatitis (8.9%), hepatitis B virus (8.9%), and idiosyncratic drug-induced liver injury (7.9%). Overall, 62 patients (10.4%) were negative for anti-HEV IgM but positive for IgG, whereas only 3 men (0.5%) were positive for both anti-HEV IgM and IgG. These 3 cases were initially diagnosed as having indeterminate, HEV, and hepatitis B virus-related ALI. One of these patients had detectable HEV RNA genotype 3, and another anti-HEV IgM+ patient had detectable HEV antigens by immunohistochemistry on liver biopsy. On multivariate modeling, older (odds ratio: 1.99) and non-Caucasian subjects (odds ratio: 2.92) were significantly more likely to have detectable anti-HEV IgG ( P < 0.0001). DISCUSSION: Acute HEV infection is an infrequent cause of ALI in hospitalized North American adults. The anti-HEV IgG+ patients were significantly older and more likely to be non-Caucasian. These data are consistent with other population-based studies that indicate exposure to HEV in the general US population is declining over time and might reflect a cohort effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14309/ctg.0000000000000273

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Overview of study population. Among the 594 patients with ALI who underwent testing, only 3 patients had detectable anti-HEV IgM (and IgG), whereas 62 patients were positive for HEV IgG but negative for IgM. The other 529 patients with ALI did not have detectable anti-HEV IgG or anti-HEV IgM. ALI, acute liver injury; HEV, hepatitis E virus.
Figure 1. Overview of study population. Among the 594 patients with ALI who underwent testing, only 3 patients had detectable anti-HEV IgM (and IgG), whereas 62 patients were positive for HEV IgG but negative for IgM. The other 529 patients with ALI did not have detectable anti-HEV IgG or anti-HEV IgM. ALI, acute liver injury; HEV, hepatitis E virus.CC BY-NC-ND · PubMed Central
Figure 2. Histopathologic features of a patient with acute hepatitis E virus (HEV) infection. (a) A mixed portal inflammation with lymphocytes, plasma cells, and eosinophils (hematoxylin and eosin, ×400). (b) Lobular disarray with cholestatic rosettes and numerous foci of inflammation (hematoxylin and eosin, original magnification ×400). (c) Immunohistochemical staining of HEV antigen using an antibody against the ORF2 of HEV. The white arrowheads indicate positive cytoplasmic staining for HEV antigen.
Figure 2. Histopathologic features of a patient with acute hepatitis E virus (HEV) infection. (a) A mixed portal inflammation with lymphocytes, plasma cells, and eosinophils (hematoxylin and eosin, ×400). (b) Lobular disarray with cholestatic rosettes and numerous foci of inflammation (hematoxylin and eosin, original magnification ×400). (c) Immunohistochemical staining of HEV antigen using an antibody against the ORF2 of HEV. The white arrowheads indicate positive cytoplasmic staining for HEV antigen.CC BY-NC-ND · PubMed Central
Figure 3. Seroprevalence of anti-HEV IgG by subject age and race. Plot of anti-HEV IgG stratified by patient age and race (Caucasian vs non-Caucasian). HEV, hepatitis E virus.
Figure 3. Seroprevalence of anti-HEV IgG by subject age and race. Plot of anti-HEV IgG stratified by patient age and race (Caucasian vs non-Caucasian). HEV, hepatitis E virus.CC BY-NC-ND · PubMed Central
Figure 4. Seroprevalence of antihepatitis E virus (HEV) IgG by Acute Liver Failure Study Group (ALFSG) site and region. There were 21 sites in the ALFSG who contributed cases to the study between 2008 and 2018. One of the 10 cases from Canada had detectable anti-HEV IgG (data not shown). *Represent states with an ALFSG clinical site.
Figure 4. Seroprevalence of antihepatitis E virus (HEV) IgG by Acute Liver Failure Study Group (ALFSG) site and region. There were 21 sites in the ALFSG who contributed cases to the study between 2008 and 2018. One of the 10 cases from Canada had detectable anti-HEV IgG (data not shown). *Represent states with an ALFSG clinical site.CC BY-NC-ND · PubMed Central
Figure 5. Persistence of anti-HEV IgG during follow-up. Solid black lines indicate 23 patients who were negative for anti-HEV IgG negative at all time points tested; black dashed lines indicates 2 patients who were positive for anti-HEV IgG during in-patient treatment but negative for anti-HEV IgG in long-term follow-up; gray dashed lines indicate 2 patients who were anti-HEV IgG positive at all time points tested. HEV, hepatitis E virus.
Figure 5. Persistence of anti-HEV IgG during follow-up. Solid black lines indicate 23 patients who were negative for anti-HEV IgG negative at all time points tested; black dashed lines indicates 2 patients who were positive for anti-HEV IgG during in-patient treatment but negative for anti-HEV IgG in long-term follow-up; gray dashed lines indicate 2 patients who were anti-HEV IgG positive at all time points tested. HEV, hepatitis E virus.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 9

Metadata

Authors
Fontana, R. J., Engle, R. E., Gottfried, M., Hammed, B., Hanje, J., Durkalski, V., Kleiner, D. E., Nguyen, H., Nishimura, N., Lee, W. M., Farci, P., & for the Acute Liver Failure Study Group
Affiliations
  • University of Michigan (US)
  • National Institute of Allergy and Infectious Diseases (US)
  • Medical University of South Carolina (US)
  • University of California, San Francisco (US)
  • The Ohio State University (US)
  • National Institutes of Health (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Fontana, Robert J.
Venue
Clinical and Translational Gastroenterology
Published
2020-11
Volume
11
Issue
11
Pages
e00273
ISSN
2155-384X (ISSN-L)
OpenAlex
W3101217433
Cited by
9
References
34
Citations by year
2025: 1 · 2024: 1 · 2023: 3 · 2022: 4
FWCI
1.03
Type
journal article
Language
en
Open access
Locations
  • Clinical and Translational Gastroenterology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058369, U01DK058369)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis Viruses Studies and Epidemiology
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Keywords
hepatitis E virus, acute liver injury, acute liver failure, anti-HEV IgG, anti-HEV IgM, HEV RNA, HEV genotype 3, acetaminophen hepatotoxicity, autoimmune hepatitis, hepatitis B virus, drug-induced liver injury, HEV seroprevalence, cohort effects, North America
MeSH terms
Acetaminophen, Adult, Age Factors, Antibodies, Viral, Biopsy, Female, Follow-Up Studies, Geography, Hepatitis Antibodies, Hepatitis B, Humans, Liver, Male, Middle Aged, Prospective Studies, Risk Factors, Severity of Illness Index, United States, Seroepidemiologic Studies, Hepatitis E, Hepatitis E virus, Liver Failure, Acute, Hepatitis Antigens, Hepatitis, Autoimmune, Young Adult, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Hepatitis E Virus Infection in North American Patients With Severe Acute Liver Injury. https://app.cochat.ai/papers/10.14309/ctg.0000000000000273
The paper
Fontana, R. J., Engle, R. E., Gottfried, M., Hammed, B., Hanje, J., Durkalski, V., Kleiner, D. E., Nguyen, H., Nishimura, N., Lee, W. M., Farci, P., & for the Acute Liver Failure Study Group. (2020). Role of Hepatitis E Virus Infection in North American Patients With Severe Acute Liver Injury. Clinical and Translational Gastroenterology. https://doi.org/10.14309/ctg.0000000000000273

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.